A citation-based method for searching scientific literature

Sonya Reid, Deborah Cragun, Ann Tezak, Anne Weidner, Jaleesa Moore, Ingrid A Mayer, Xiao-Ou Shu, Fei Ye, Run Fan, Susan Vadaparampil, Tuya Pal. Genet Med 2020
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative.
Jennifer L Caswell-Jin, Anjali D Zimmer, Will Stedden, Kerry E Kingham, Alicia Y Zhou, Allison W Kurian. J Natl Cancer Inst 2019
37
100


The evolutionary history of 2,658 cancers.
Moritz Gerstung, Clemency Jolly, Ignaty Leshchiner, Stefan C Dentro, Santiago Gonzalez, Daniel Rosebrock, Thomas J Mitchell, Yulia Rubanova, Pavana Anur, Kaixian Yu,[...]. Nature 2020
181
100

Linkage of early-onset familial breast cancer to chromosome 17q21.
J M Hall, M K Lee, B Newman, J E Morrow, L A Anderson, B Huey, M C King. Science 1990
100

Pathogenic Germline Variants in 10,389 Adult Cancers.
Kuan-Lin Huang, R Jay Mashl, Yige Wu, Deborah I Ritter, Jiayin Wang, Clara Oh, Marta Paczkowska, Sheila Reynolds, Matthew A Wyczalkowski, Ninad Oak,[...]. Cell 2018
241
100

National cancer control plans: a global analysis.
Yannick Romero, Dario Trapani, Sonali Johnson, Zuzanna Tittenbrun, Leslie Given, Karin Hohman, Lisa Stevens, Julie S Torode, Mathieu Boniol, André M Ilbawi. Lancet Oncol 2018
34
100

Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.
Rachel S van der Post, Ingrid P Vogelaar, Fátima Carneiro, Parry Guilford, David Huntsman, Nicoline Hoogerbrugge, Carlos Caldas, Karen E Chelcun Schreiber, Richard H Hardwick, Margreet G E M Ausems,[...]. J Med Genet 2015
280
100

Residential exposure to solar ultraviolet radiation and incidence of childhood hematological malignancies in France.
Astrid Coste, Stéphanie Goujon, Mathieu Boniol, Fabienne Marquant, Laure Faure, Jean-François Doré, Denis Hémon, Jacqueline Clavel. Cancer Causes Control 2015
12
100

Selection of family members for communication of cancer risk and barriers to this communication before and after genetic cancer risk assessment.
Deborah J MacDonald, Linda Sarna, Gwen van Servellen, Roshan Bastani, Joyce Newman Giger, Jeffrey N Weitzel. Genet Med 2007
47
100

The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews.
P Hartge, J P Struewing, S Wacholder, L C Brody, M A Tucker. Am J Hum Genet 1999
156
100

Genomics of Cancer and a New Era for Cancer Prevention.
Paul Brennan, Christopher P Wild. PLoS Genet 2015
14
100

Population genetic testing for cancer susceptibility: founder mutations to genomes.
William D Foulkes, Bartha Maria Knoppers, Clare Turnbull. Nat Rev Clin Oncol 2016
61
100


A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
Saundra S Buys, John F Sandbach, Amanda Gammon, Gayle Patel, John Kidd, Krystal L Brown, Lavania Sharma, Jennifer Saam, Johnathan Lancaster, Mary B Daly. Cancer 2017
168
100

Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons.
Eric R Manahan, Henry M Kuerer, Molly Sebastian, Kevin S Hughes, Judy C Boughey, David M Euhus, Susan K Boolbol, Walton A Taylor. Ann Surg Oncol 2019
52
100

Characterization of BRCA1 and BRCA2 mutations in a large United States sample.
Sining Chen, Edwin S Iversen, Tara Friebel, Dianne Finkelstein, Barbara L Weber, Andrea Eisen, Leif E Peterson, Joellen M Schildkraut, Claudine Isaacs, Beth N Peshkin,[...]. J Clin Oncol 2006
218
100


Bilateral risk-reduction mastectomy in BRCA1 and BRCA2 mutation carriers: a meta-analysis.
Francesca De Felice, Claudia Marchetti, Angela Musella, Innocenza Palaia, Giorgia Perniola, Daniela Musio, Ludovico Muzii, Vincenzo Tombolini, Pierluigi Benedetti Panici. Ann Surg Oncol 2015
31
100

Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.
E Warner, W Foulkes, P Goodwin, W Meschino, J Blondal, C Paterson, H Ozcelik, P Goss, D Allingham-Hawkins, N Hamel,[...]. J Natl Cancer Inst 1999
294
100

Genomics of disease risk in globally diverse populations.
Deepti Gurdasani, Inês Barroso, Eleftheria Zeggini, Manjinder S Sandhu. Nat Rev Genet 2019
66
100

Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer.
Anne Marie McCarthy, Mirar Bristol, Susan M Domchek, Peter W Groeneveld, Younji Kim, U Nkiru Motanya, Judy A Shea, Katrina Armstrong. J Clin Oncol 2016
73
100


Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award.
Mary-Claire King, Ephrat Levy-Lahad, Amnon Lahad. JAMA 2014
172
100

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
Catherine M Phelan, Karoline B Kuchenbaecker, Jonathan P Tyrer, Siddhartha P Kar, Kate Lawrenson, Stacey J Winham, Joe Dennis, Ailith Pirie, Marjorie J Riggan, Ganna Chornokur,[...]. Nat Genet 2017
130
100


Diagnostic yield and clinical utility of a comprehensive gene panel for hereditary tumor syndromes.
Jonas Henn, Isabel Spier, Ronja S Adam, Stefanie Holzapfel, Siegfried Uhlhaas, Katrin Kayser, Guido Plotz, Sophia Peters, Stefan Aretz. Hered Cancer Clin Pract 2019
4
100

The bigger picture of FTO: the first GWAS-identified obesity gene.
Ruth J F Loos, Giles S H Yeo. Nat Rev Endocrinol 2014
263
100

The risk of breast cancer in BRCA1 and BRCA2 mutation carriers without a first-degree relative with breast cancer.
K A Metcalfe, J Lubinski, J Gronwald, T Huzarski, J McCuaig, H T Lynch, B Karlan, W D Foulkes, C F Singer, S L Neuhausen,[...]. Clin Genet 2018
7
100

A snapshot of current genetic testing practice in Lynch syndrome: The results of a representative survey of 33 Latin American existing centres/registries.
Adriana Della Valle, Benedito Mauro Rossi, Edenir Inêz Palmero, Marina Antelo, Carlos Alberto Vaccaro, Francisco López-Kostner, Karin Alvarez, Marcia Cruz-Correa, Luisina Inés Bruno, Nora Manoukian Forones,[...]. Eur J Cancer 2019
7
100

Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients.
Beth Crawford, Sophie B Adams, Taylor Sittler, Jeroen van den Akker, Salina Chan, Ofri Leitner, Lauren Ryan, Elad Gil, Laura van 't Veer. Breast Cancer Res Treat 2017
47
100

Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer.
Nimmi S Kapoor, Lisa D Curcio, Carlee A Blakemore, Amy K Bremner, Rachel E McFarland, John G West, Kimberly C Banks. Ann Surg Oncol 2015
66
100

Availability and payer coverage of BRCA1/2 tests and gene panels.
Elizabeth Clain, Julia R Trosman, Michael P Douglas, Christine B Weldon, Kathryn A Phillips. Nat Biotechnol 2015
17
100

Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care.
Patricia Ashton-Prolla, Juliana Giacomazzi, Aishameriane V Schmidt, Fernanda L Roth, Edenir I Palmero, Luciane Kalakun, Ernestina S Aguiar, Susana M Moreira, Erica Batassini, Vanessa Belo-Reyes,[...]. BMC Cancer 2009
38
100


Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry.
Gabriela C Fernandes, Rodrigo A D Michelli, Henrique C R Galvão, André E Paula, Rui Pereira, Carlos E Andrade, Paula S Felicio, Cristiano P Souza, Deise R P Mendes, Sahlua Volc,[...]. Oncotarget 2016
31
100


The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study.
Robert Carreras-Torres, Mattias Johansson, Valerie Gaborieau, Philip C Haycock, Kaitlin H Wade, Caroline L Relton, Richard M Martin, George Davey Smith, Paul Brennan. J Natl Cancer Inst 2017
95
100

Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing.
Donavan T Cheng, Meera Prasad, Yvonne Chekaluk, Ryma Benayed, Justyna Sadowska, Ahmet Zehir, Aijazuddin Syed, Yan Elsa Wang, Joshua Somar, Yirong Li,[...]. BMC Med Genomics 2017
53
100

Evaluating the Utility of Polygenic Risk Scores in Identifying High-Risk Individuals for Eight Common Cancers.
Guochong Jia, Yingchang Lu, Wanqing Wen, Jirong Long, Ying Liu, Ran Tao, Bingshan Li, Joshua C Denny, Xiao-Ou Shu, Wei Zheng. JNCI Cancer Spectr 2020
11
100

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.
C Oddoux, J P Struewing, C M Clayton, S Neuhausen, L C Brody, M Kaback, B Haas, L Norton, P Borgen, S Jhanwar,[...]. Nat Genet 1996
296
100


Prevalence of Hispanic BRCA1 and BRCA2 mutations among hereditary breast and ovarian cancer patients from Brazil reveals differences among Latin American populations.
Bárbara Alemar, Josef Herzog, Cristina Brinckmann Oliveira Netto, Osvaldo Artigalás, Ida Vanessa D Schwartz, Camila Matzenbacher Bittar, Patricia Ashton-Prolla, Jeffrey N Weitzel. Cancer Genet 2016
22
100

Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing.
Jacqueline Mersch, Nichole Brown, Sara Pirzadeh-Miller, Erin Mundt, Hannah C Cox, Krystal Brown, Melissa Aston, Lisa Esterling, Susan Manley, Theodora Ross. JAMA 2018
76
100

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
B B Roa, A A Boyd, K Volcik, C S Richards. Nat Genet 1996
543
100

Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing.
Tom Walsh, Ming K Lee, Silvia Casadei, Anne M Thornton, Sunday M Stray, Christopher Pennil, Alex S Nord, Jessica B Mandell, Elizabeth M Swisher, Mary-Claire King. Proc Natl Acad Sci U S A 2010
324
100

Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States.
Farhad Islami, Ann Goding Sauer, Kimberly D Miller, Rebecca L Siegel, Stacey A Fedewa, Eric J Jacobs, Marjorie L McCullough, Alpa V Patel, Jiemin Ma, Isabelle Soerjomataram,[...]. CA Cancer J Clin 2018
339
100

False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care.
Stephany Tandy-Connor, Jenna Guiltinan, Kate Krempely, Holly LaDuca, Patrick Reineke, Stephanie Gutierrez, Phillip Gray, Brigette Tippin Davis. Genet Med 2018
109
100

Use and Patient-Reported Outcomes of Clinical Multigene Panel Testing for Cancer Susceptibility in the Multicenter Communication of Genetic Test Results by Telephone Study.
Michael J Hall, Linda J Patrick-Miller, Brian L Egleston, Susan M Domchek, Mary B Daly, Pamela Ganschow, Generosa Grana, Olufunmilayo I Olopade, Dominique Fetzer, Amanda Brandt,[...]. JCO Precis Oncol 2018
8
100

Meta-analysis of genome-wide association studies for height and body mass index in ∼700000 individuals of European ancestry.
Loic Yengo, Julia Sidorenko, Kathryn E Kemper, Zhili Zheng, Andrew R Wood, Michael N Weedon, Timothy M Frayling, Joel Hirschhorn, Jian Yang, Peter M Visscher. Hum Mol Genet 2018
434
100

Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
Amanda Meneses Ferreira, Vania Balderrama Brondani, Vanessa Petry Helena, Helaine Laiz Silva Charchar, Maria Claudia Nogueira Zerbini, Luiz Antonio Senna Leite, Ana Oliveira Hoff, Ana Claudia Latronico, Berenice Bilharinho Mendonca, Maria Del Pilar Estevez Diz,[...]. J Steroid Biochem Mol Biol 2019
6
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.